Elexacaftor
ATC R07AX32 · 5 markets · 22 records
AU 9 records · 5 strengths
- 100 mgtabletTrikaftaTRIKAFTA 100/50/75 elexacaftor 100 mg / tezacaftor 50 mg / ivacaftor 75 mg film-coated tablet and ivacaftor 150 mg film-coated tablet blister composite pack
- 50 mgtabletTrikaftaTRIKAFTA 50/25/37.5 elexacaftor 50 mg/tezacaftor 25 mg/ivacaftor 37.5 mg film-coated tablet and ivacaftor 75 mg film-coated tablet blister pack composite pack
- 100 mgpowderTrikaftaTRIKAFTA 100/50/75 GRANULES elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor 75 mg granules and ivacaftor 75 mg granules sachet composite pack
- 80 mgpowderTrikaftaTRIKAFTA 80/40/60 GRANULES elexacaftor 80 mg/tezacaftor 40 mg/ivacaftor 60 mg granules and ivacaftor 59.5 mg granules sachet composite pack
Records without a stated strength · 1 Trikafta
GB 4 records · 4 strengths
- 100 mgtabletKaftrio 75mg/50mg/100mg tablets
- 50 mgtabletKaftrio 75mg/50mg/100mg tablets
- 100 mgpowderKaftrio 60mg/40mg/80mg granules sachets
- 80 mgpowderKaftrio 60mg/40mg/80mg granules sachets
CA 4 records · 4 strengths
ES 4 records · 4 strengths
- 100 mgtabletKaftrio 75mg/50mg/100mg tablets
- 50 mgtabletKaftrio 75mg/50mg/100mg tablets
- 100 mgliquidKaftrio 75mg/50mg/100mg tablets
- 80 mgliquidKaftrio 75mg/50mg/100mg tablets
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Kaftrio 75mg/50mg/100mg tablets
| Strength / form / release | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|
| 100 mg tablet | Kaftrio 75mg/50mg/100mg tablets | Trikafta | Trikafta TRIKAFTA 100/50/75 elexacaftor 100 mg / tezacaftor 50 mg / ivacaftor 75 mg film-coated tablet and ivacaftor 150 mg film-coated tablet blister composite pack | Kaftrio 75mg/50mg/100mg tablets | |
| 50 mg tablet | Kaftrio 75mg/50mg/100mg tablets | Trikafta | Trikafta TRIKAFTA 50/25/37.5 elexacaftor 50 mg/tezacaftor 25 mg/ivacaftor 37.5 mg film-coated tablet and ivacaftor 75 mg film-coated tablet blister pack composite pack | Kaftrio 75mg/50mg/100mg tablets | |
| 100 mg powder | Kaftrio 60mg/40mg/80mg granules sachets | Trikafta | Trikafta TRIKAFTA 100/50/75 GRANULES elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor 75 mg granules and ivacaftor 75 mg granules sachet composite pack | ||
| 80 mg powder | Kaftrio 60mg/40mg/80mg granules sachets | Trikafta | Trikafta TRIKAFTA 80/40/60 GRANULES elexacaftor 80 mg/tezacaftor 40 mg/ivacaftor 60 mg granules and ivacaftor 59.5 mg granules sachet composite pack | ||
| 100 mg liquid | Kaftrio 75mg/50mg/100mg tablets | ||||
| 80 mg liquid | Kaftrio 75mg/50mg/100mg tablets | ||||
unknown | Trikafta | Kaftrio 75mg/50mg/100mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.